Mednet Logo

What is your simulation setup and dose fractionation for DLBCL of the hand with Deauville 4 residual disease following R-CHOP?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Duke University Medical Center
Answered on

This is a difficult question which I will break into 2 parts: 1) Rx of primary refractory (i.e. chemotherapy resistant) localized DLBCL and 2) special considerations for a hand site. I presume the recurrent/persistent disease is still localized.

Treatment of primary refractory DLBCL is a very difficu...

Join for free or sign in to see the full answer